In particular, IL-36γ was shown to enhance the effector functions of CD8+ T cells, NK cells and γδ T cells, to transform the tumor microenvironment into one favoring tumor destruction, and ultimately to have profound anti-tumor effects, suppressing both tumor growth and metastasis. This evidence concerns the gene CD8A and neoplasm.